Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients
Receiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study ai...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140090/ https://www.ncbi.nlm.nih.gov/pubmed/35626884 http://dx.doi.org/10.3390/children9050707 |
_version_ | 1784715013787746304 |
---|---|
author | Tran, Denise D. Brown, Patrick C. M. Murphy, Corrin Ho, Diana Hudson, Karen A. Wilson, Anna C. Feldstein Ewing, Sarah W. |
author_facet | Tran, Denise D. Brown, Patrick C. M. Murphy, Corrin Ho, Diana Hudson, Karen A. Wilson, Anna C. Feldstein Ewing, Sarah W. |
author_sort | Tran, Denise D. |
collection | PubMed |
description | Receiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study aimed to evaluate pediatric PO label instructions provided to a large sample of pediatric outpatients. Data were extracted from the electronic healthcare records system identifying pediatric patients who received a PO between 2016 and 2019 from pediatric outpatient medical clinics were affiliated with a northwestern United States medical center and children’s hospital. Pediatric patients (n = 12,613) between 0–17 years old who received a PO during outpatient care were included. Patients with chronic health conditions (e.g., cancer) or who received their PO from an inpatient medical setting were excluded. Patient demographics, medication instructions, associated diagnoses, and other prescription information (e.g., name of medication, dose, and quantity dispensed) were examined using automated text classification. Many label instructions did not include any indication/reason for use (20.8%). Virtually none of the POs (>99%) included instructions for how to reduce/wean off POs, contact information for questions about the POs, and/or instructions around how to dispose of the POs. Efforts are needed to ensure that pediatric PO instructions contain essential elements to improve comprehension of when and how to use POs for pediatric patients. |
format | Online Article Text |
id | pubmed-9140090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91400902022-05-28 Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients Tran, Denise D. Brown, Patrick C. M. Murphy, Corrin Ho, Diana Hudson, Karen A. Wilson, Anna C. Feldstein Ewing, Sarah W. Children (Basel) Article Receiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study aimed to evaluate pediatric PO label instructions provided to a large sample of pediatric outpatients. Data were extracted from the electronic healthcare records system identifying pediatric patients who received a PO between 2016 and 2019 from pediatric outpatient medical clinics were affiliated with a northwestern United States medical center and children’s hospital. Pediatric patients (n = 12,613) between 0–17 years old who received a PO during outpatient care were included. Patients with chronic health conditions (e.g., cancer) or who received their PO from an inpatient medical setting were excluded. Patient demographics, medication instructions, associated diagnoses, and other prescription information (e.g., name of medication, dose, and quantity dispensed) were examined using automated text classification. Many label instructions did not include any indication/reason for use (20.8%). Virtually none of the POs (>99%) included instructions for how to reduce/wean off POs, contact information for questions about the POs, and/or instructions around how to dispose of the POs. Efforts are needed to ensure that pediatric PO instructions contain essential elements to improve comprehension of when and how to use POs for pediatric patients. MDPI 2022-05-11 /pmc/articles/PMC9140090/ /pubmed/35626884 http://dx.doi.org/10.3390/children9050707 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tran, Denise D. Brown, Patrick C. M. Murphy, Corrin Ho, Diana Hudson, Karen A. Wilson, Anna C. Feldstein Ewing, Sarah W. Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title_full | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title_fullStr | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title_full_unstemmed | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title_short | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
title_sort | evaluating providers’ prescription opioid instructions to pediatric patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140090/ https://www.ncbi.nlm.nih.gov/pubmed/35626884 http://dx.doi.org/10.3390/children9050707 |
work_keys_str_mv | AT trandenised evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT brownpatrickcm evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT murphycorrin evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT hodiana evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT hudsonkarena evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT wilsonannac evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT feldsteinewingsarahw evaluatingprovidersprescriptionopioidinstructionstopediatricpatients |